In Vitro and In Vivo Bioequivalence Study of 3D-Printed Instant-Dissolving Levetiracetam Tablets and Subsequent Personalized Dosing for Chinese Children Based on Physiological Pharmacokinetic Modeling
Open Access
- 22 December 2021
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (1) , 20
Abstract
Recently, the development of Binder Jet 3D printing technology has promoted the research and application of personalized formulations, which are especially useful for children’s medications. Additionally, physiological pharmacokinetic (PBPK) modeling can be used to guide drug development and drug dose selection. Multiple technologies can be used in combination to increase the safety and effectiveness of drug administration. In this study, we performed in vivo pharmacokinetic experiments in dogs with preprepared 3D-printed levetiracetam instant-dissolving tablets (LEV-IDTs). Bioequivalence analysis showed that the tablets were bioequivalent to commercially available preparations (Spritam®) for dogs. Additionally, we evaluated the bioequivalence of 3D-printed LEV-IDTs with Spritam® by a population-based simulation based on the established PBPK model of levetiracetam for Chinese adults. Finally, we established a PBPK model of oral levetiracetam in Chinese children by combining the physiological parameters of children, and we simulated the PK (pharmacokinetics) curves of Chinese children aged 4 and 6 years that were administered the drug to provide precise guidance on adjusting the dose according to the effective dose range of the drug. Briefly, utilizing both Binder jet 3D printing technology and PBPK models is a promising route for personalized drug delivery with various age groups.Keywords
Funding Information
- Beijing Natural Science Foundation of China (No. L202043)
- National Natural Science Foundation of China (No. 82073793)
This publication has 28 references indexed in Scilit:
- Prospective Predictions of Human Pharmacokinetics for Eighteen CompoundsJournal of Pharmaceutical Sciences, 2015
- Application of Absorption Modeling to Predict Bioequivalence Outcome of Two Batches of Etoricoxib TabletsAAPS PharmSciTech, 2014
- PBPK models for the prediction of in vivo performance of oral dosage formsEuropean Journal of Pharmaceutical Sciences, 2014
- Physiologically Based Pharmacokinetic (PBPK) Modeling in ChildrenClinical Pharmacology & Therapeutics, 2012
- Population pharmacokinetics modeling of levetiracetam in Chinese children with epilepsyActa Pharmacologica Sinica, 2012
- Simulation of Human Intravenous and Oral Pharmacokinetics of 21 Diverse Compounds Using Physiologically Based Pharmacokinetic ModellingClinical Pharmacokinetics, 2011
- Prediction of Human Pharmacokinetics Using Physiologically Based Modeling: A Retrospective Analysis of 26 Clinically Tested DrugsDrug Metabolism and Disposition, 2007
- A Novel Strategy for Physiologically Based Predictions of Human PharmacokineticsClinical Pharmacokinetics, 2006
- Volume of Distribution at Steady State for a Linear Pharmacokinetic System with Peripheral EliminationJournal of Pharmaceutical Sciences, 2004
- Pharmacokinetic profile of levetiracetamPharmacology & Therapeutics, 2000